Kbc Group Nv Biolife Solutions Inc Transaction History

Kbc Group Nv

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 15, 2024	SELL	$10.81 - $22.96 $8,604 - $18,276	-796 Reduced 30.91%	1,779 $25,000
Q3 2022 Feb 15, 2024	BUY	$14.64 - $26.7 $37,698 - $68,752	2,575 New	2,575 $59,000
Q2 2022 Feb 14, 2024	BUY	$10.54 - $24.2 $27,140 - $62,315	2,575 New	2,575 $36,000
Q2 2022 Jul 26, 2022	BUY	$10.54 - $24.2 $27,140 - $62,315	2,575 New	2,575 $36,000
Q4 2021 Feb 03, 2022	SELL	$32.99 - $58.55 $36,289 - $64,405	-1,100 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$14.59 - $18.9 $21,593 - $27,971	-1,480 Reduced 57.36%	1,100 $18,000
Q3 2019 Nov 07, 2019	BUY	$15.7 - $20.98 $23,236 - $31,050	1,480 Added 134.55%	2,580 $42,000
Q2 2019 Dec 03, 2019	BUY	$15.2 - $19.42 $16,720 - $21,362	1,100 New	1,100 $20,000
Q2 2019 Jul 30, 2019	SELL	$15.2 - $19.42 $16,720 - $21,362	-1,100 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$10.9 - $21.26 $11,990 - $23,386	1,100 New	1,100 $20,000
Q1 2019 May 10, 2019	SELL	$10.9 - $21.26 $11,990 - $23,386	-1,100 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$9.5 - $17.17 $10,450 - $18,887	1,100 New	1,100 $13,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.